multiple-sclerosis

Documents about multiple-sclerosis

• Exercise Effects in Multiple Sclerosis#835061ClinicalTrials.gov
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis#967988ClinicalTrials.gov
• A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis#851458ClinicalTrials.gov
• Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS)#833128ClinicalTrials.gov
• Obe-cel in Refractory Progressive Forms of Multiple Sclerosis#833704ClinicalTrials.gov
• Simvastatin in Secondary Progressive Multiple Sclerosis#899581ClinicalTrials.gov
• Metformin Treatment in Progressive Multiple Sclerosis#861080ClinicalTrials.gov
• Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis#859774ClinicalTrials.gov
• Cognitive Reserve-building Activities in Multiple Sclerosis#830781ClinicalTrials.gov
• IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study#902459ClinicalTrials.gov
• Lubiprostone in Patients With Multiple Sclerosis Associated Constipation#898889ClinicalTrials.gov
• Care in Multiple Sclerosis (MS)#917133ClinicalTrials.gov
• GER-009-06-AVX Early Therapy in Multiple Sclerosis#841243ClinicalTrials.gov
• Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis#426644ClinicalTrials.gov
• Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis#829730ClinicalTrials.gov
• Solriamfetol for the Treatment of Multiple Sclerosis Fatigue#877413ClinicalTrials.gov
• Dry Needling for Treating Spasticity in Multiple Sclerosis#898537ClinicalTrials.gov
• Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)#902779ClinicalTrials.gov
• Testing the Effects of Methylphenidate on Multiple Sclerosis#902944ClinicalTrials.gov
• Ofatumumab Dose-finding in Relapsing Remitting Multiple Sclerosis (RRMS) Patients#905481ClinicalTrials.gov
• Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis#918843ClinicalTrials.gov
• Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS).#910159ClinicalTrials.gov
• Lorraine Registry of Multiple Sclerosis#831508ClinicalTrials.gov
• Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis#810615ClinicalTrials.gov
• Functional Outcomes From Diets in Multiple Sclerosis#832497ClinicalTrials.gov
• Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS#891049ClinicalTrials.gov
• A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis#968599ClinicalTrials.gov
• Immunogenicity and Safety of Subcutaneously-administered Avonex (Interferon Beta-1a) in Multiple Sclerosis (MS) Patients#884996ClinicalTrials.gov
• COMparison Between All immunoTherapies for Multiple Sclerosis.#363614ClinicalTrials.gov
• LEMTRADA Pregnancy Registry in Multiple Sclerosis#889817ClinicalTrials.gov
• Pediatric Onset Multiple Sclerosis in Egyptians#911446ClinicalTrials.gov
• Use of an Electronic Diary by People With Multiple Sclerosis#834186ClinicalTrials.gov
• Open-label Study of Liothyronine in MS#855210ClinicalTrials.gov
• Fatigue and Mental Well-Being in MS Patients(Multiple Sclerosis)#861434ClinicalTrials.gov
• A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis#864624ClinicalTrials.gov
• Short-term B-cell Depletion in Relapsing Multiple Sclerosis#230342ClinicalTrials.gov
• Applications of Nanotechnology in Multiple Sclerosis by Respiratory Samples#230428ClinicalTrials.gov
• Physical Telerehabilitation in Multiple Sclerosis#811991ClinicalTrials.gov
• Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis#825162ClinicalTrials.gov
• Advanced MRI Sequences in Multiple Sclerosis and Its Mimics#848471ClinicalTrials.gov
• STAT4 in Multiple Sclerosis by PCR and Flow Cytometry#851566ClinicalTrials.gov
• Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study#801891ClinicalTrials.gov
• Natalizumab Treatment of Progressive Multiple Sclerosis#843810ClinicalTrials.gov
• Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis#906929ClinicalTrials.gov
• Treatment Adherence When Using RebiSmart™ in Relapsing Multiple Sclerosis Subjects#828209ClinicalTrials.gov
• Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis#834833ClinicalTrials.gov
• Endurance and Walking Training by Nordic Walking in Multiple Sclerosis#837351ClinicalTrials.gov
• Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study#841353ClinicalTrials.gov
• Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis#846830ClinicalTrials.gov
• TMP001 in Relapsing-remitting Multiple Sclerosis#848192ClinicalTrials.gov

Related topics